Home INDUSTRY news TMG Partners Sign Clovis Oncology to 10-Year Lease for 32,000 SQFT at 133O Broadway in Oakland
INDUSTRY newsNews Releases

TMG Partners Sign Clovis Oncology to 10-Year Lease for 32,000 SQFT at 133O Broadway in Oakland

Share
TMG Partners, Bay Area, Clovis Oncology, Oakland, Mission Bay, San Francisco, Arup, Oracle, BART, Cushman & Wakefield, JLL
Photo courtesy: TMG Partners
Share

OAKLAND, Calif. (November 27, 2017) – TMG Partners, one of the Bay Area’s largest mixed-use property developers, announced today that biopharmaceutical company Clovis Oncology (NASDAQ: CLVS), an innovator in cancer drugs, signed a ten-year lease for 32,000 square feet at the developer’s 1330 Broadway property in Downtown Oakland. Clovis is expanding its footprint from Mission […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Prologis Files Plans for 514,000 SQFT Data Center on Charcot Avenue in North San Jose

Prologis wants to tear down five aging North San Jose industrial buildings...

Essex Property Trust Lands $275MM Bank of America-Led Term Loan to Retire Commercial Paper

Essex Property Trust has lined up $275 million of unsecured bank debt...

Wells Fargo Sees Higher Rate Floor Squeezing Bay Area Housing as AI Buildout Powers Data Centers

Wells Fargo's latest economic outlook argues that a structurally higher floor under...

AI Mega-IPOs Push Bay Area Exit Value Past $300B, Quadrupling All of 2025

The San Francisco Bay Area captured more than $300 billion in expansion-stage...